Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
life sciences
national blog main
accelerated approval
acute hepatic porphyria
alnylam pharmaceuticals
aminolevulinic acid
boston
boston blog main
boston top stories
cannabidiol
dravet syndrome
epidiolex
fda
fen-phen
fenfluramine
givosiran
gw pharmaceuticals
lennox-gastaut syndrome
rna interference
san francisco
san francisco blog main
san francisco top stories
zogenix
What
data
drug
2
×
market
2
×
medicine
2
×
pharmaceuticals
2
×
ago
alnylam
approved
battle
cannabis
cleared
derivative
epilepsy
far
fda
form
gw
gw’s
interference
marijuana
nasdaq
new
ok
rare
rna
rnai
second
seek
sets
speedy
weeks
zogenix
Language
Current search:
pharmaceuticals
×
drug
×
market
×
medicine
×
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug